Mettler-Toledo International (NYSE:MTD) Issues Q2 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 10.700-10.850 for the period, compared to the consensus estimate of 10.960. The company issued revenue guidance of $1.0 billion-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Mettler-Toledo International also updated its FY 2026 guidance to 46.300-46.950 EPS.

Mettler-Toledo International Stock Down 0.5%

Shares of MTD stock traded down $6.61 on Thursday, hitting $1,320.43. The stock had a trading volume of 198,733 shares, compared to its average volume of 150,680. The company has a market cap of $26.74 billion, a PE ratio of 31.35, a P/E/G ratio of 2.73 and a beta of 1.31. The business has a 50 day moving average price of $1,277.68 and a 200 day moving average price of $1,367.88. Mettler-Toledo International has a one year low of $1,077.19 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 EPS for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. The business had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the company posted $12.41 earnings per share. Equities research analysts expect that Mettler-Toledo International will post 46.51 EPS for the current year.

Analyst Upgrades and Downgrades

MTD has been the topic of several recent analyst reports. Morgan Stanley cut their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Barclays lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Jefferies Financial Group upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and upped their price objective for the stock from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $1,459.58.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.71% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Mettler-Toledo International by 0.4% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 272,829 shares of the medical instruments supplier’s stock worth $380,375,000 after acquiring an additional 1,052 shares during the period. Invesco Ltd. raised its holdings in shares of Mettler-Toledo International by 24.5% during the 4th quarter. Invesco Ltd. now owns 235,342 shares of the medical instruments supplier’s stock worth $328,111,000 after acquiring an additional 46,342 shares during the period. Bank of America Corp DE raised its holdings in shares of Mettler-Toledo International by 56.8% during the 3rd quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock worth $157,276,000 after acquiring an additional 46,402 shares during the period. Amundi raised its holdings in shares of Mettler-Toledo International by 6.9% during the 4th quarter. Amundi now owns 118,568 shares of the medical instruments supplier’s stock worth $165,306,000 after acquiring an additional 7,641 shares during the period. Finally, Williams Jones Wealth Management LLC. raised its holdings in shares of Mettler-Toledo International by 0.8% during the 4th quarter. Williams Jones Wealth Management LLC. now owns 105,265 shares of the medical instruments supplier’s stock worth $146,759,000 after acquiring an additional 855 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.